Location History:
- Bensalem, PA (US) (2018 - 2021)
- Doylestown, PA (US) (2023)
Company Filing History:
Years Active: 2018-2023
Title: Innovations of Fang Moore in Pharmaceutical Chemistry
Introduction
Fang Moore is a notable inventor based in Bensalem, PA (US), recognized for her contributions to pharmaceutical chemistry. She has been instrumental in developing innovative compounds that target specific integrins, which play a crucial role in various diseases.
Latest Patents
Fang Moore holds 3 patents, with her latest inventions focusing on cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors. These compounds are designed to act as antagonists to αv-containing integrins. The inventions also encompass pharmaceutical compositions that utilize these compounds for treating diseases associated with dysregulation of αV-containing integrins, including pathological fibrosis, transplant rejection, cancer, osteoporosis, and inflammatory disorders.
Career Highlights
Fang Moore is currently employed at Bristol-Myers Squibb Company, where she continues to advance her research in the field of integrin inhibitors. Her work has significant implications for developing new therapeutic strategies for various medical conditions.
Collaborations
Fang collaborates with esteemed colleagues, including Pratik Devasthale and Guohua Zhao, to enhance the scope and impact of her research.
Conclusion
Fang Moore's innovative work in pharmaceutical chemistry exemplifies the vital role of inventors in advancing medical science. Her contributions to integrin inhibitors are paving the way for new treatments that could significantly improve patient outcomes.